Unique ID issued by UMIN | UMIN000023874 |
---|---|
Receipt number | R000027437 |
Scientific Title | A cross-sectional study of cancer screening behavior and smoking behavior among people with serious mental illness. |
Date of disclosure of the study information | 2016/09/01 |
Last modified on | 2022/06/22 08:55:27 |
A cross-sectional study of cancer screening behavior and smoking behavior among people with serious mental illness.
Health-related behaviors and serious mental illness
A cross-sectional study of cancer screening behavior and smoking behavior among people with serious mental illness.
Health-related behaviors and serious mental illness
Japan |
Schizophrenia (including schizoaffective disorder)
Psychiatry |
Others
NO
This study aims to investigate the utilization of cancer screening and smoking behavior, and to identify the factors associated with those health-related behaviors among people with schizophrenia.
Others
Others
Prevalence of cancer screenings
Distribution of stages in the process of quitting smoking
Observational
20 | years-old | <= |
69 | years-old | >= |
Male and Female
Diagnosis of schizophrenia or schizoaffective disorder according to the DSM-5 criteria.
Patients who have visited the hospital of the study site for 1 or more years.
Patients who visited the hospital twice or more in the last 6 months.
Aged between 20 and 69 years.
Diagnosis of intellectual disability, substance/medication-induced psychotic disorder, or psychotic disorder due to another medical condition
Patients who are not appropriate for participation in the study as judged by the physician
Patients who do not read or write in Japanese
420
1st name | Norihito |
Middle name | |
Last name | Yamada |
Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences
Department of Neuropsychiatry
700-8558
2-5-1, Shikata-cho, Kita-ku, Okayama, 700-8558, Japan.
086-235-7246
nyamada@okayama-u.ac.jp
1st name | Masaki |
Middle name | |
Last name | Fujiwara |
Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences
Department of Neuropsychiatry
700-8558
2-5-1, Shikata-cho, Kita-ku, Okayama, 700-8558, Japan.
086-235-7246
mfujiwara@okayama-u.ac.jp
Department of Neuropsychiatry, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Science
Okayama Health Foundation
Novartis Pharma Research Grants
Okayama University
Research for Promotion of Cancer Control Programs (H26-political-general-002)
Other
Okayama Psychiatric Medical Center
Department of Preventive Medicine and Epidemiology, Tohoku Medical Megabank Organization, Tohoku University
Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences and Okayama University Hospital, Ethics Committee
2-5-1, Shikata-cho, Kita-ku, Okayama, 700-8558, Japan.
086-235-6938
mae6605@adm.okayama-u.ac.jp
NO
2016 | Year | 09 | Month | 01 | Day |
NA
Published
https://doi.org/10.1111/pcn.12554
350
https://doi.org/10.1111/pcn.12554
https://doi.org/10.1620/tjem.244.209
https://doi.org/10.1186/s12888-019-2351-9
https://doi.org/10.18926/AMO/62226
2022 | Year | 06 | Month | 22 | Day |
2017 | Year | 09 | Month | 05 | Day |
https://doi.org/10.1111/pcn.12554
https://doi.org/10.1111/pcn.12554
none
https://doi.org/10.1111/pcn.12554
Completed
2015 | Year | 12 | Month | 15 | Day |
2016 | Year | 02 | Month | 23 | Day |
2016 | Year | 09 | Month | 01 | Day |
2017 | Year | 11 | Month | 30 | Day |
-Cancer screening
1) Main
The point estimates and 95% confidence intervals (CIs) for prevalences of cancer screenings in the population.
2) Secondary
(a) The point estimates and 95% CIs for prevalences of cancer screenings stratified by age, severity (GAF), and gender. (b) The odds ratio of the GAF adjusted for demographic variables, socioeconomic variables, course of illness, self-rated health status, psychological distress, physician recommendation for receiving cancer screenings, and smoking status. (c) Exploratory analysis of odds ratios of other variables. (d) The associations between disability (WHODAS 2.0) and utilization of cancer screenings assessed by the multiple logistic regression analysis. (e) The cross-tabulated tables of the self-report utilization of cancer screenings versus the utilization of cancer screenings from the record of the municipality.
-Smoking behavior
1) Main
The point estimate and 95% CI for the proportion of each stages in the process of quitting smoking in the population.
2) Secondary
(a) The odds ratio of the GAF adjusted for demographic variables, socioeconomic status, course of illness, self-rated health status, psychological distress, physician recommendation for smoking cessation, and quantity of antipsychotics by the multiple logistic regression analysis. (b) The associations between the heavy smoking index and independent variables by the multiple regression analysis. (c) The proportion of methods of quitting smoking used by past smoker and current smoker.
3) Preliminary longitudinal study
The proportions of smoking behaviors in the next year in patients categorized as smokers in the 2016 study.
-Validity of WHODAS 2.0
The validity of the Japanese version of WHODAS 2.0 (12-item self-administration version).
2016 | Year | 08 | Month | 31 | Day |
2022 | Year | 06 | Month | 22 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000027437
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |